Array Liam Condon, Managing Director of Bayer Healthcare China discusses the government’s recent announcements regarding its much-anticipated healthcare reform plan, the future benefits of investing in rural healthcare, and the company’s main ambitions in China over the next five years. It has been a rollercoaster four years…
HUYA Bioscience International - China Your business is very much relationship based here in China. You’ve now established a number of relationships with institutes, universities and companies, but I can imagine that breaking into this market and building those relationships was a challenge. How did you grow this business in the early days? The early…
MSD Brasil When we were in Australia, we met with the “star scientist” Ian Frazier, who was Australian of the Year in 2009 for his co-discovery of Merck’s Gardasil. Or Singulair, which is the trade name of Montelukast, with the Mont signifying “Montreal” where the product was developed. What will it take…
Productos Medix S.A. de C.V. Can you tell us a little about the history of Medix and about the company itself? Medix is a 100% Mexican company created in 1956, and our major strength is that we produce products and services that are differentiated from the rest of the market, and have added-value. When Medix…
APOTEX Mexico Apotex has increased production, launched 16 new products last March, and grown significantly in the market. What would you say has been the biggest change in the market over the last four years? Mexico has a very dynamic pharmaceutical industry that changes one day to the next, and to give…
Randall Laboratories When we saw you in 2008 we had read a little bit about the major milestones in the company, how your grandfather came to Mexico in the 1950s and how you used to come to work in the company every day after high school when you were a teenager. Randall…
Stendhal Mexico Please can you tell our readers a little bit more about the history of Stendhal, and its major milestones along the way since its takeover in 1997? Stendhal is a privately owned company that has presence throughout LatinAmerica. It was bought by its current owners in 1997 and by 2003…
Novartis Farmaceutica S.A. de C.V. (Mexico) Carlos Garcia said in December 2009 that 6-8% of Novartis’ annual revenue comes from Latin America, and that the area is “one of the main growth engines for the company”. Can you tell us how Novartis Mexico fits in with that growth strategy? Mexico is the second biggest market in…
Agendia Agendia has experienced remarkable growth in the seven years since you founded the company. In 2009 you expanded the company’s Amsterdam facilities and, in 2010, you doubled the size of its U.S. facilities. Why this drastic expansion, especially over the last two years? Agendia continues to grow at a rapid…
Alliance Healthcare Russia You took over this organization just three months ago, having previously headed businesses in industries as diverse as retail, food, and automobiles. What drew you to Alliance Healthcare Russia? Do you find similarities between this job and your previous positions? When I decided to leave my former position, I decided…
Apposite Capital LLP As a partner at Apposite since the company was created in 2006, what was the founding vision of the company and what do you consider have been its major milestones in the last five years? Apposite was conceived as a new venture capital (VC)/ Private equity (PE) fund that would…
Apitope Apitope’s research and success is based on its High Speed Technology Platform that uses soluble peptides as vehicles to regulate immune responses in patients. What is the history behind this technology and how does it differ from other peptide-based research? Apitope was founded on a platform technology to discover peptides…
See our Cookie Privacy Policy Here